The global epidemic of cardiometabolic disease demands the continual refinement of cardiometabolic care approaches and strategies. As the nation's premier event in cardiometabolic medicine, the 16th Annual Cardiometabolic Health Congress has been curated by the field's leading experts to deliver to you the latest evidence-based interventions to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.

EDUCATIONAL OBJECTIVES

• Discuss the interrelationships among cardiometabolic risk factors and their impact on the development of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease
• Interpret the latest evidence and guidelines for the prevention, screening, and treatment of the complex patient with cardiometabolic risk or cardiometabolic disease
• Outline strategies aimed at timely screening and prevention of cardiometabolic disease, including assessment of risk factors and biomarkers, and lifestyle modifications
• Develop individualized treatment regimens for patients with cardiometabolic disease based on the efficacy and safety of current and new pharmacotherapies, patient comorbidities and preferences in order to optimize outcomes
• Summarize recent evidence for emerging therapies in order to stay current with the most recent updates in the cardiometabolic field
• Recognize the impacts of rare cardiometabolic diseases, including rare lipid, cardiovascular, diabetes, and obesity disorders, as well as potential implications for management